Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134169) titled 'Study on the Mechanism by which SLC38A4 promotes aerobic glycolysis and cancer progression in gastric cancer cells through the FKBP10-mediated AKT pathway' on Oct. 11.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Chongqing General Hospital
Condition:
Gastric cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Observation group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304405
Disclaimer: Curated by HT Syndication....